Back to Farallon Capital Management, L.L.C. Farallon Capital Management, L.L.C.

CYTKCYTK

Showing 2 of 20 quarters

Position history for Farallon Capital Management, L.L.C.Farallon Capital Management, L.L.C.'s holdings in Cytokinetics, Incorporated

No. Farallon Capital Management exited its CYTK (Cytokinetics) position in Q4 2024. Its Q3 2024 13F listed 102,400 shares worth $5.4M. Farallon Capital Management first reported CYTK in Q1 2020 and held it in 19 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$5.4M

Total Shares Change

-102,400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$47.04
0
2024-Q3
Unchanged
102,400
0.0%
$5.4M0.0%$52.80
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used